CHOYP_ABCA1.2.3	P41233	m.11687	sp	ABCA1_MOUSE	40	675	344	13	258	903	1180	1822	1.21E-130	437	ABCA1_MOUSE	reviewed	ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1)	x	Abca1 Abc1	Mus musculus (Mouse)	2261	cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G-protein coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis, engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cAMP biosynthetic process [GO:0030819]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to low-density lipoprotein particle [GO:0055098]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691]	GO:0002790; GO:0005102; GO:0005524; GO:0005548; GO:0005794; GO:0005886; GO:0005887; GO:0006497; GO:0006911; GO:0007040; GO:0007186; GO:0007584; GO:0008203; GO:0008509; GO:0009897; GO:0010875; GO:0016197; GO:0017127; GO:0019905; GO:0030139; GO:0030819; GO:0031267; GO:0032367; GO:0032489; GO:0033344; GO:0033700; GO:0034185; GO:0034186; GO:0034188; GO:0034364; GO:0034380; GO:0034616; GO:0042157; GO:0042158; GO:0042493; GO:0042626; GO:0042632; GO:0043231; GO:0043691; GO:0045121; GO:0045332; GO:0045335; GO:0048471; GO:0050702; GO:0051117; GO:0055091; GO:0055098; GO:0060155; GO:0071222; GO:0071300; GO:0071397	0	0	0	PF00005;	59	m.11687	135848.2857	5214020.5	320156	1375048.889	232384.7143	267251.5556	520005.75	1782210.364	1596007.75	748949.4167	0.675294117
CHOYP_AIFM1.1.1	O95831	m.1582	sp	AIFM1_HUMAN	47.135	541	262	8	70	601	83	608	1.24E-157	468	AIFM1_HUMAN	reviewed	Apoptosis-inducing factor 1, mitochondrial (EC 1.1.1.-) (Programmed cell death protein 8)	x	AIFM1 AIF PDCD8	Homo sapiens (Human)	613	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cell redox homeostasis [GO:0045454]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; chromosome condensation [GO:0030261]; DNA catabolic process [GO:0006308]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]; response to toxic substance [GO:0009636]	GO:0002931; GO:0003677; GO:0005634; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006308; GO:0006915; GO:0006919; GO:0009055; GO:0009636; GO:0016174; GO:0016651; GO:0030182; GO:0030261; GO:0032981; GO:0043065; GO:0043525; GO:0045454; GO:0048471; GO:0051402; GO:0070059; GO:0070301; GO:0071392; GO:0071732; GO:0071949; GO:0090650; GO:1902065; GO:1902510; GO:1904045	0	0	0	PF14721;PF07992;	222	m.1582	973976.6	84310	1359083.667	479589.75	315224.8	3251126.5	300368	479530.6	1802073.6	1379353.222	2.245341515
CHOYP_BRAFLDRAFT_119799.1.1	P30044	m.23765	sp	PRDX5_HUMAN	59.524	168	66	1	18	183	43	210	7.18E-69	211	PRDX5_HUMAN	reviewed	Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)	x	PRDX5 ACR1 SBBI10	Homo sapiens (Human)	214	cell redox homeostasis [GO:0045454]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription from RNA polymerase III promoter [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]	GO:0000302; GO:0001016; GO:0004601; GO:0005102; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006954; GO:0006979; GO:0008379; GO:0016209; GO:0016480; GO:0031410; GO:0032967; GO:0034614; GO:0042744; GO:0043027; GO:0043066; GO:0043231; GO:0045454; GO:0046983; GO:0048471; GO:0051354; GO:0051920; GO:0060785; GO:0070062; GO:0070995; GO:0072541; GO:2001057	0	0	0	PF08534;	478	m.23765	23982944.17	13890076.81	4635772	2601289.75	17147594.83	1161584.636	5768779.182	967580.7	5408679.8	31874359.25	0.725709428
CHOYP_BRAFLDRAFT_90929.1.1	Q14831	m.54455	sp	GRM7_HUMAN	27.789	475	300	13	538	988	46	501	2.19E-46	184	GRM7_HUMAN	reviewed	Metabotropic glutamate receptor 7 (mGluR7)	x	GRM7 GPRC1G MGLUR7	Homo sapiens (Human)	915	adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway [GO:0007196]; adult behavior [GO:0030534]; chemical synaptic transmission [GO:0007268]; conditioned taste aversion [GO:0001661]; multicellular organismal response to stress [GO:0033555]; negative regulation of adenylate cyclase activity [GO:0007194]; negative regulation of cAMP biosynthetic process [GO:0030818]; negative regulation of glutamate secretion [GO:0014050]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; short-term memory [GO:0007614]; transmission of nerve impulse [GO:0019226]	GO:0001642; GO:0001661; GO:0005245; GO:0005246; GO:0005509; GO:0005886; GO:0005887; GO:0005938; GO:0007194; GO:0007196; GO:0007268; GO:0007605; GO:0007608; GO:0007614; GO:0008066; GO:0010855; GO:0014050; GO:0016021; GO:0016595; GO:0019226; GO:0030165; GO:0030424; GO:0030425; GO:0030534; GO:0030818; GO:0032279; GO:0033555; GO:0042734; GO:0043198; GO:0043235; GO:0045211; GO:0048786; GO:0051966; GO:0070905	0	0	0	PF00003;PF01094;PF07562;	1032	m.54454	93479	30483	43294	74151	132143	217504	35097	1817412.333	20942003.5	1019406.5	64.33254807
CHOYP_CATA.1.3	Q9PWF7	m.11120	sp	CATA_RUGRU	66.794	262	86	1	44	305	238	498	1.91E-124	369	CATA_RUGRU	reviewed	Catalase (EC 1.11.1.6)	x	cat	Rugosa rugosa (Japanese wrinkled frog) (Glandirana rugosa)	528	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096; GO:0005777; GO:0006979; GO:0020037; GO:0042744; GO:0046872	0	0	0	PF00199;PF06628;	1164	m.11120	217389.2857	189117.2222	414395.2	616062.8462	733193.4286	391679.2727	255387.3	239523.8333	424081.4	375916.75	0.777173169
CHOYP_CRYAB.2.5	P04792	m.23200	sp	HSPB1_HUMAN	37.234	94	57	2	46	138	89	181	2.28E-09	58.5	HSPB1_HUMAN	reviewed	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	x	HSPB1 HSP27 HSP28	Homo sapiens (Human)	205	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028	0	0	0	PF00011;	1764	m.23201	483273.625	372271.3333	7342004.5	286184.5	542089.5	246745.6667	4659260.889	1075265.714	1637214.4	3352081.083	1.215464473
CHOYP_DNJC3.1.1	Q27968	m.52309	sp	DNJC3_BOVIN	55.4	500	210	6	50	536	5	504	0	526	DNJC3_BOVIN	reviewed	DnaJ homolog subfamily C member 3 (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)	x	DNAJC3 P58IPK	Bos taurus (Bovine)	504	cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; response to unfolded protein [GO:0006986]	GO:0004860; GO:0005783; GO:0005829; GO:0006469; GO:0006986; GO:0019901; GO:0036494; GO:0070417; GO:1903912	0	0	cd06257;	PF00226;PF09976;PF13181;	1897	m.52309	680976.5	340475.7143	285811.25	195196.1111	87705.2	422222.4286	100637.6	1724223.714	462403.7143	208907.375	1.835278254
CHOYP_DPER_GL22446.1.1	P04792	m.52315	sp	HSPB1_HUMAN	37.838	74	45	1	28	100	95	168	1.34E-11	61.2	HSPB1_HUMAN	reviewed	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	x	HSPB1 HSP27 HSP28	Homo sapiens (Human)	205	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028	0	0	0	PF00011;	1904	m.52315	636340	340809.8333	7943169.909	362777.6667	568209	237382.25	5959749.143	1408708.4	1734680.25	4352681.556	1.389988397
CHOYP_DPER_GL22446.1.1	P42930	m.52312	sp	HSPB1_RAT	35.443	79	50	1	46	123	93	171	3.49E-06	47.8	HSPB1_RAT	reviewed	Heat shock protein beta-1 (HspB1) (Heat shock 27 kDa protein) (HSP 27)	x	Hspb1 Hsp27	Rattus norvegicus (Rat)	206	aging [GO:0007568]; cellular response to butyrate [GO:1903545]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-11 [GO:0071348]; female pregnancy [GO:0007565]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced cell death [GO:1903202]; positive regulation of neuron projection development [GO:0010976]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to muscle stretch [GO:0035994]	GO:0000502; GO:0002931; GO:0005634; GO:0005737; GO:0005819; GO:0005886; GO:0007565; GO:0007568; GO:0010976; GO:0030424; GO:0030425; GO:0031430; GO:0031674; GO:0035994; GO:0043066; GO:0043130; GO:0043204; GO:0045202; GO:0070301; GO:0071348; GO:0097512; GO:0098839; GO:1903202; GO:1903545; GO:1990776	0	0	0	PF00011;	1903	m.52311	150372	1061472	56760	1460974	15160	131588.5	1822599	21110	39365	431946	0.891381436
CHOYP_G6PD.1.2	P05370	m.38380	sp	G6PD_RAT	68.487	476	140	5	62	530	9	481	0	692	G6PD_RAT	reviewed	Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49)	x	G6pdx G6pd	Rattus norvegicus (Rat)	515	cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADPH regeneration [GO:0006740]; NADP metabolic process [GO:0006739]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390]; substantia nigra development [GO:0021762]	GO:0004345; GO:0005536; GO:0005634; GO:0005813; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0021762; GO:0030246; GO:0032094; GO:0034599; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:0070062; GO:1904879; GO:2000378	PATHWAY: Carbohydrate degradation; pentose phosphate pathway; D-ribulose 5-phosphate from D-glucose 6-phosphate (oxidative stage): step 1/3.	0	0	PF02781;PF00479;	2201	m.38380	1144157	3013439.8	549546.5385	607411.3077	1562046.636	428645.9091	6152029.4	527677.4545	567266.2857	1130303.455	1.280563194
CHOYP_GSK3B.1.1	Q9WV60	m.62139	sp	GSK3B_MOUSE	79.167	408	78	4	1	401	1	408	0	666	GSK3B_MOUSE	reviewed	Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1)	x	Gsk3b	Mus musculus (Mouse)	420	aging [GO:0007568]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in positive regulation of apoptotic process [GO:0044337]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to dopamine [GO:1903351]; cellular response to erythropoietin [GO:0036018]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-3 [GO:0036016]; cellular response to iron(II) ion [GO:0071282]; cellular response to lithium ion [GO:0071285]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of NFAT protein import into nucleus [GO:0051534]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; organ morphogenesis [GO:0009887]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule-based process [GO:0032886]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron projection development [GO:0010975]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to drug [GO:0042493]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to insulin [GO:0032868]; response to insulin-like growth factor stimulus [GO:1990418]; response to L-glutamate [GO:1902065]; response to ultrasound [GO:1990478]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055]	GO:0000320; GO:0001085; GO:0001837; GO:0001954; GO:0002039; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006349; GO:0006468; GO:0006611; GO:0006983; GO:0007010; GO:0007409; GO:0007520; GO:0007568; GO:0007623; GO:0008013; GO:0008283; GO:0009887; GO:0010614; GO:0010628; GO:0010800; GO:0010918; GO:0010975; GO:0010977; GO:0014043; GO:0014069; GO:0014823; GO:0014902; GO:0016020; GO:0016055; GO:0016301; GO:0016310; GO:0016477; GO:0018105; GO:0018107; GO:0019901; GO:0021766; GO:0030010; GO:0030424; GO:0030426; GO:0030529; GO:0030877; GO:0031333; GO:0031334; GO:0031625; GO:0032091; GO:0032092; GO:0032355; GO:0032436; GO:0032868; GO:0032886; GO:0033138; GO:0034236; GO:0034392; GO:0035372; GO:0035556; GO:0035729; GO:0036016; GO:0036018; GO:0042493; GO:0043025; GO:0043066; GO:0043197; GO:0043198; GO:0043227; GO:0043407; GO:0043525; GO:0043547; GO:0044027; GO:0044297; GO:0044337; GO:0045121; GO:0045444; GO:0045773; GO:0045944; GO:0046777; GO:0046827; GO:0048168; GO:0048471; GO:0048661; GO:0050321; GO:0050774; GO:0051001; GO:0051059; GO:0051534; GO:0060070; GO:0070059; GO:0070301; GO:0071109; GO:0071260; GO:0071282; GO:0071285; GO:0071871; GO:0097192; GO:1901030; GO:1901216; GO:1902065; GO:1903351; GO:1904339; GO:1990418; GO:1990478; GO:1990776; GO:1990909; GO:2000463; GO:2000573; GO:2000727; GO:2000738; GO:2001223	0	0	0	PF00069;	2283	m.62139	1432424.833	243861	732079	327384.2	105283.3333	515224	2014174	669985	1655806.667	180484	1.772480218
CHOYP_HMCN1.44.44	A4IGL7	m.67044	sp	PXDN_XENTR	27.966	354	217	15	7	355	287	607	2.55E-29	124	PXDN_XENTR	reviewed	Peroxidasin (EC 1.11.1.7)	x	pxdn pxn	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	1457	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005576; GO:0006979; GO:0020037; GO:0042744; GO:0046872	0	0	0	PF03098;PF07679;PF13855;PF00093;	2324	m.67044	550553.4	25633	NA	616589.5	41867	860098	102608	122130.5	322093	1078181.333	1.610253998
CHOYP_HS74L.1.1	O95757	m.24610	sp	HS74L_HUMAN	51.001	849	390	10	1	833	1	839	0	850	HS74L_HUMAN	reviewed	Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94)	x	HSPA4L APG1 OSP94	Homo sapiens (Human)	839	protein folding [GO:0006457]; response to unfolded protein [GO:0006986]	GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0006986	0	0	0	PF00012;	2362	m.24610	2872580.188	112740.7857	4411670.667	1201676.667	1124563.429	1094158.353	3284951.133	2351002.5	872038.6667	267942.5882	0.809411259
CHOYP_HS90A.1.3	P04809	m.7724	sp	HSP83_DROPS	80.184	434	84	1	18	451	269	700	0	735	HSP83_DROPS	reviewed	Heat shock protein 83 (HSP 82)	x	Hsp83 Hsp82 GA11622	Drosophila pseudoobscura pseudoobscura (Fruit fly)	717	protein folding [GO:0006457]; response to stress [GO:0006950]	GO:0005524; GO:0005737; GO:0006457; GO:0006950	0	0	0	PF02518;PF00183;	2363	m.7724	7325354.96	10949054.77	9864588.92	5515392.909	5017594.406	7180385.591	13770965.14	6327870.893	59548259.7	3882865.063	2.34563455
CHOYP_HS90A.3.3	Q90474	m.28299	sp	H90A1_DANRE	77.655	631	135	5	21	647	97	725	0	983	H90A1_DANRE	reviewed	Heat shock protein HSP 90-alpha 1	x	hsp90a.1 hsp90 hsp90a hsp90aa1 zgc:86652	Danio rerio (Zebrafish) (Brachydanio rerio)	725	leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; response to metal ion [GO:0010038]; response to stress [GO:0006950]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0005524; GO:0006457; GO:0006950; GO:0007517; GO:0010038; GO:0014866; GO:0030018; GO:0030235; GO:0030239; GO:0030240; GO:0030241; GO:0031672; GO:0042470; GO:0045429; GO:0048471; GO:0048769; GO:0050900; GO:0071688	0	0	0	PF02518;PF00183;	2365	m.28299	6336167.448	9992789.118	8415240.6	5084407.194	4785630.914	5979604.593	12388561.62	5766617.969	53132814.89	3463185.139	2.332300095
CHOYP_HYOU1.3.3	Q9Y4L1	m.28442	sp	HYOU1_HUMAN	43.75	208	108	3	2	207	739	939	5.24E-41	154	HYOU1_HUMAN	reviewed	Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170)	x	HYOU1 GRP170 ORP150	Homo sapiens (Human)	999	cellular response to hypoxia [GO:0071456]; ER to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903382]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; receptor-mediated endocytosis [GO:0006898]; response to endoplasmic reticulum stress [GO:0034976]; response to ischemia [GO:0002931]	GO:0002931; GO:0005524; GO:0005576; GO:0005783; GO:0005788; GO:0005790; GO:0005925; GO:0006888; GO:0006898; GO:0016020; GO:0034663; GO:0034976; GO:0036498; GO:0051087; GO:0070062; GO:0071456; GO:0071682; GO:1903298; GO:1903382	0	0	0	PF00012;	2406	m.28442	349834.6667	186919	5250015.75	857059	43037	349373.6667	765713.5	458386	121379.3333	39706.5	0.259397923
CHOYP_ISCW_ISCW008219.1.2	P08228	m.46822	sp	SODC_MOUSE	70.588	153	45	0	4	156	2	154	1.28E-74	223	SODC_MOUSE	reviewed	Superoxide dismutase [Cu-Zn] (EC 1.15.1.1)	x	Sod1	Mus musculus (Mouse)	154	activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antibiotic [GO:0046677]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226]	GO:0000187; GO:0000302; GO:0000303; GO:0001541; GO:0001819; GO:0001895; GO:0001975; GO:0002262; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005758; GO:0005764; GO:0005777; GO:0005829; GO:0005886; GO:0006749; GO:0006801; GO:0006879; GO:0006979; GO:0007283; GO:0007566; GO:0007568; GO:0007569; GO:0007605; GO:0007626; GO:0008089; GO:0008090; GO:0008217; GO:0008270; GO:0009408; GO:0010033; GO:0019226; GO:0019430; GO:0030346; GO:0031012; GO:0031045; GO:0031410; GO:0031667; GO:0032287; GO:0032839; GO:0032930; GO:0034465; GO:0035865; GO:0040014; GO:0042493; GO:0042542; GO:0042554; GO:0042802; GO:0043025; GO:0043066; GO:0043085; GO:0043087; GO:0043209; GO:0043234; GO:0043524; GO:0045471; GO:0045541; GO:0045859; GO:0046677; GO:0046688; GO:0046716; GO:0048365; GO:0048678; GO:0050665; GO:0051087; GO:0051881; GO:0060047; GO:0060052; GO:0060087; GO:0060088; GO:0070062; GO:0071276; GO:0071318; GO:0072593; GO:0097332; GO:1902177; GO:1904115	0	0	cd00305;	PF00080;	2475	m.46822	3670563.4	468776.25	492295.75	89802.83333	365171.2222	320819.5	281210	369576.8571	1610264.2	335148	0.573470124
CHOYP_ISCW_ISCW010532.2.4	Q9NL98	m.35454	sp	PRDX_ASCSU	73.846	195	51	0	1	195	1	195	8.32E-109	312	PRDX_ASCSU	reviewed	Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase)	x	0	Ascaris suum (Pig roundworm) (Ascaris lumbricoides)	195	cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979]	GO:0004601; GO:0005737; GO:0006979; GO:0008379; GO:0016209; GO:0045454	0	0	0	PF10417;PF00578;	2487	m.35454	512133.2857	399627.7778	254216.5714	592246.3333	459379.875	69883.16667	284040.1429	196095.6	1176951.833	368687	0.945009971
CHOYP_ISCW_ISCW012366.1.1	P53563	m.3692	sp	B2CL1_RAT	30.921	152	96	3	115	258	82	232	7.30E-17	80.5	B2CL1_RAT	reviewed	Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X)	x	Bcl2l1 Bclx Blc2l	Rattus norvegicus (Rat)	233	aging [GO:0007568]; apoptotic process [GO:0006915]; cerebral cortex development [GO:0021987]; cytokinesis [GO:0000910]; endocytosis [GO:0006897]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; ovarian follicle development [GO:0001541]; regulation of apoptotic process [GO:0042981]; response to electrical stimulus [GO:0051602]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to ischemia [GO:0002931]; response to lead ion [GO:0010288]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to oxidative stress [GO:0006979]; response to peptide hormone [GO:0043434]	GO:0000910; GO:0001541; GO:0001666; GO:0002931; GO:0005739; GO:0005740; GO:0005741; GO:0005743; GO:0005759; GO:0005813; GO:0005829; GO:0006897; GO:0006915; GO:0006979; GO:0007093; GO:0007568; GO:0008630; GO:0010035; GO:0010243; GO:0010288; GO:0014070; GO:0016021; GO:0021987; GO:0030054; GO:0030672; GO:0031965; GO:0042542; GO:0042803; GO:0042981; GO:0043027; GO:0043066; GO:0043434; GO:0046982; GO:0051400; GO:0051602; GO:0097192; GO:0097371; GO:2001243	0	0	0	PF00452;PF02180;	2495	m.3691	5954836.833	449406	266357.1667	375873	197061.8334	206763.75	2988434.8	1828123.5	183205.75	485289.75	0.785778999
CHOYP_ISCW_ISCW014481.1.1	P56524	m.61217	sp	HDAC4_HUMAN	44.028	1013	420	27	99	1005	93	1064	0	732	HDAC4_HUMAN	reviewed	Histone deacetylase 4 (HD4) (EC 3.5.1.98)	x	HDAC4 KIAA0288	Homo sapiens (Human)	1084	B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to mechanical stimulus [GO:0071260]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to tumor necrosis factor [GO:0071356]; chromatin modification [GO:0016568]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; inflammatory response [GO:0006954]; negative regulation of cell proliferation [GO:0008285]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of sequence-specific DNA binding transcription factor activity [GO:0043433]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription from RNA polymerase II promoter [GO:0000122]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of sequence-specific DNA binding transcription factor activity [GO:0051091]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression, epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle fiber development [GO:0048742]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to drug [GO:0042493]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]; transcription, DNA-templated [GO:0006351]	GO:0000118; GO:0000122; GO:0001025; GO:0001047; GO:0001501; GO:0002076; GO:0003682; GO:0003714; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006338; GO:0006351; GO:0006954; GO:0007399; GO:0008134; GO:0008270; GO:0008284; GO:0008285; GO:0010592; GO:0010832; GO:0010882; GO:0014894; GO:0014898; GO:0014911; GO:0016568; GO:0016575; GO:0017053; GO:0030018; GO:0030183; GO:0030955; GO:0031594; GO:0031672; GO:0032041; GO:0033235; GO:0033558; GO:0033613; GO:0034983; GO:0040029; GO:0042113; GO:0042493; GO:0042641; GO:0042826; GO:0043393; GO:0043433; GO:0043525; GO:0045668; GO:0045820; GO:0045892; GO:0045893; GO:0045944; GO:0048661; GO:0048742; GO:0051091; GO:0070491; GO:0070555; GO:0070932; GO:0070933; GO:0071260; GO:0071356; GO:0071374; GO:1903428	0	0	0	PF12203;PF00850;	2505	m.61217	1761534	1532941	3260356.75	682510	30869	NA	20216773.75	903436	3183750	95814	4.196317118
CHOYP_LOC100114171.1.1	O42254	m.50280	sp	IF2B1_CHICK	35.333	600	342	13	22	601	1	574	9.14E-106	333	IF2B1_CHICK	reviewed	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zip-code binding polypeptide) (Zipcode-binding protein 1) (ZBP-1)	x	IGF2BP1 VICKZ1 ZBP1	Gallus gallus (Chicken)	576	CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610]	GO:0000166; GO:0003729; GO:0003730; GO:0005634; GO:0010494; GO:0010610; GO:0010976; GO:0017148; GO:0022013; GO:0030027; GO:0030175; GO:0030426; GO:0045182; GO:0048027; GO:0048471; GO:0051028; GO:0070934; GO:0070937; GO:0097150	0	0	0	PF00013;PF00076;	2706	m.50280	365245.2	211759.5455	573434.7059	582694.7857	1516110.75	917042.8333	1333250.333	482998.8462	1581996.059	366701.4286	1.440946903
CHOYP_LOC100174996.1.1	P42297	m.27300	sp	YXIE_BACSU	27.586	145	97	4	4	141	5	148	2.50E-09	55.5	YXIE_BACSU	reviewed	Universal stress protein YxiE (USP YxiE)	x	yxiE BSU39250 N17E	Bacillus subtilis (strain 168)	148	response to stress [GO:0006950]	GO:0006950	0	0	0	PF00582;	2800	m.27300	15768	10356709	51504	92034	2104413.667	45672	14985274	31533	57969	138696	1.209082861
CHOYP_LOC100177679.1.1	P74148	m.54177	sp	Y1388_SYNY3	28.824	170	104	6	11	180	2	154	2.95E-13	67.4	Y1388_SYNY3	reviewed	Universal stress protein Sll1388 (USP Sll1388)	x	sll1388	Synechocystis sp. (strain PCC 6803 / Kazusa)	154	response to stress [GO:0006950]	GO:0006950	0	0	0	PF00582;	2812	m.54177	16813	149382	482708	31923	80985	808288	16392	2398202	1484143	203691	6.446108024
CHOYP_LOC100180023.4.7	Q2FXL6	m.33650	sp	Y1819_STAA8	30.303	165	85	5	15	177	7	143	7.54E-10	58.2	Y1819_STAA8	reviewed	Putative universal stress protein SAOUHSC_01819	x	SAOUHSC_01819	Staphylococcus aureus (strain NCTC 8325)	166	response to stress [GO:0006950]	GO:0005737; GO:0006950	0	0	0	PF00582;	2822	m.33650	NA	68444	120155	211663	63945	3433784.5	22435	99430	13806	863883	7.640278583
CHOYP_LOC100180023.5.7	A0QZA1	m.56825	sp	Y3950_MYCS2	28.571	154	94	4	4	153	10	151	4.48E-10	59.7	Y3950_MYCS2	reviewed	Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950)	x	MSMEG_3950 MSMEI_3859	Mycobacterium smegmatis (strain ATCC 700084 / mc(2)155)	294	response to stress [GO:0006950]	GO:0006950	0	0	0	PF00582;	2823	m.56825	20097	103615	324919	NA	27665	NA	12744413	23790	20127.5	24708	26.9014195
CHOYP_LOC100180023.6.7	P74897	m.63800	sp	YQA3_THEAQ	40.26	77	36	1	76	142	61	137	3.77E-08	52	YQA3_THEAQ	reviewed	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	x	0	Thermus aquaticus	137	response to stress [GO:0006950]	GO:0006950	0	0	0	PF00582;	2824	m.63800	126517.5	1692581	562901.6667	444647.3333	27671.66667	19255766.75	118501.3333	1829603.333	367406	24992483.78	16.31343885
CHOYP_LOC100180855.1.4	Q2FXL6	m.29179	sp	Y1819_STAA8	33.813	139	87	4	15	150	7	143	7.12E-12	62.8	Y1819_STAA8	reviewed	Putative universal stress protein SAOUHSC_01819	x	SAOUHSC_01819	Staphylococcus aureus (strain NCTC 8325)	166	response to stress [GO:0006950]	GO:0005737; GO:0006950	0	0	0	PF00582;	2831	m.29179	NA	68444	120155	211663	63945	3433784.5	22435	99430	13806	863883	7.640278583
CHOYP_LOC100180855.2.4	Q8LGG8	m.46097	sp	USPAL_ARATH	28.261	138	87	5	14	141	27	162	2.22E-11	61.6	USPAL_ARATH	reviewed	Universal stress protein A-like protein	x	At3g01520 F4P13.7	Arabidopsis thaliana (Mouse-ear cress)	175	response to stress [GO:0006950]	GO:0005886; GO:0006950; GO:0016208	0	0	0	PF00582;	2832	m.46097	993920	202067.5	146146.5	298265	1299322.5	83000	1563098.333	370494	50451	321543	0.812521299
CHOYP_LOC100181607.2.2	O07552	m.55285	sp	NHAX_BACSU	26.25	160	102	4	73	216	7	166	5.90E-09	56.6	NHAX_BACSU	reviewed	Stress response protein NhaX	x	nhaX yheK BSU09690	Bacillus subtilis (strain 168)	166	response to stress [GO:0006950]	GO:0006950	0	0	0	PF00582;	2841	m.55285	494980	31084	64158.5	223025.3333	128777	205825.5	269893	22560	621286	133610.6667	1.330299502
CHOYP_LOC100211409.1.1	P04792	m.4742	sp	HSPB1_HUMAN	38.667	75	43	2	161	233	95	168	3.82E-10	60.8	HSPB1_HUMAN	reviewed	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	x	HSPB1 HSP27 HSP28	Homo sapiens (Human)	205	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028	0	0	0	PF00011;	2894	m.4742	651414.5556	337618.1	6317623.786	378199.4438	467184	338760.75	3826765.727	2681237.5	1244984.25	2706129.875	1.324561491
CHOYP_LOC100371043.4.5	P00184	m.34262	sp	CP1A1_MOUSE	25.688	109	80	1	10	118	178	285	1.49E-06	49.3	CP1A1_MOUSE	reviewed	Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-P1)	x	Cyp1a1 Cyp1a-1	Mus musculus (Mouse)	524	9-cis-retinoic acid biosynthetic process [GO:0042904]; aging [GO:0007568]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cell proliferation [GO:0008283]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; digestive tract development [GO:0048565]; drug metabolic process [GO:0017144]; embryo development ending in birth or egg hatching [GO:0009792]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; heterocycle metabolic process [GO:0046483]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; maternal process involved in parturition [GO:0060137]; oxidation-reduction process [GO:0055114]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to antibiotic [GO:0046677]; response to arsenic-containing substance [GO:0046685]; response to drug [GO:0042493]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; response to vitamin A [GO:0033189]; response to wounding [GO:0009611]; toxin metabolic process [GO:0009404]	GO:0001666; GO:0004497; GO:0005506; GO:0005739; GO:0005789; GO:0006778; GO:0007568; GO:0008283; GO:0008395; GO:0009308; GO:0009404; GO:0009611; GO:0009615; GO:0009624; GO:0009635; GO:0009636; GO:0009792; GO:0009804; GO:0009812; GO:0010041; GO:0016491; GO:0016679; GO:0016711; GO:0016712; GO:0017143; GO:0017144; GO:0020037; GO:0031090; GO:0032094; GO:0032451; GO:0032496; GO:0033189; GO:0035902; GO:0042493; GO:0042904; GO:0043010; GO:0043231; GO:0046483; GO:0046677; GO:0046685; GO:0048565; GO:0050665; GO:0055093; GO:0055114; GO:0060137; GO:0070330; GO:0070365; GO:0070576; GO:0071407; GO:1900087	0	0	0	PF00067;	3191	m.34263	186407	54401	1397167	260581.6667	22764.5	44155.5	298899.5	131393	65384.5	302437	0.438380378
CHOYP_LOC100374573.1.1	P31689	m.24523	sp	DNJA1_HUMAN	65.594	404	125	5	1	398	1	396	4.75E-179	506	DNJA1_HUMAN	reviewed	DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2)	x	DNAJA1 DNAJ2 HDJ2 HSJ2 HSPF4	Homo sapiens (Human)	397	androgen receptor signaling pathway [GO:0030521]; DNA damage response, detection of DNA damage [GO:0042769]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; sperm motility [GO:0030317]; toxin transport [GO:1901998]	GO:0001664; GO:0005524; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0006986; GO:0007283; GO:0009408; GO:0016020; GO:0030317; GO:0030521; GO:0030544; GO:0030957; GO:0031397; GO:0031625; GO:0042769; GO:0043065; GO:0043066; GO:0043508; GO:0046872; GO:0048471; GO:0050750; GO:0051087; GO:0051223; GO:0055131; GO:0070062; GO:0070585; GO:0098554; GO:1901998; GO:1903748; GO:1905259	0	0	cd06257;	PF00226;PF01556;PF00684;	3405	m.24523	309802.2	353796.6667	79159	386589.25	1288476.2	1920633.333	342487	276688	117232	4563791.667	2.986501102
CHOYP_LOC100377173.1.2	P04792	m.37699	sp	HSPB1_HUMAN	38.667	75	43	2	161	233	95	168	1.68E-09	59.3	HSPB1_HUMAN	reviewed	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	x	HSPB1 HSP27 HSP28	Homo sapiens (Human)	205	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028	0	0	0	PF00011;	3596	m.37698	2755969.8	72264.1	698586.8667	685428.0769	198614.6667	379931.6667	524564.4615	294265.0833	1047699.833	1460404.467	0.840394518
CHOYP_LOC589012.1.1	P16056	m.26892	sp	MET_MOUSE	27.807	748	441	24	42	731	635	1341	4.59E-74	266	MET_MOUSE	reviewed	Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)	x	Met	Mus musculus (Mouse)	1379	activation of MAPK activity [GO:0000187]; adult behavior [GO:0030534]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; chemical synaptic transmission [GO:0007268]; endothelial cell morphogenesis [GO:0001886]; excitatory postsynaptic potential [GO:0060079]; glucose homeostasis [GO:0042593]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; modulation of synaptic transmission [GO:0050804]; muscle cell migration [GO:0014812]; muscle organ development [GO:0007517]; myoblast proliferation [GO:0051450]; myotube differentiation [GO:0014902]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of transforming growth factor beta production [GO:0071635]; placenta development [GO:0001890]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of glucose transport [GO:0010828]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; protein autophosphorylation [GO:0046777]; reactive oxygen species metabolic process [GO:0072593]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of interleukin-6 production [GO:0032675]; semaphorin-plexin signaling pathway [GO:0071526]; skeletal muscle tissue development [GO:0007519]	GO:0000187; GO:0001886; GO:0001889; GO:0001890; GO:0004672; GO:0005008; GO:0005524; GO:0007268; GO:0007420; GO:0007517; GO:0007519; GO:0009925; GO:0009986; GO:0010629; GO:0010828; GO:0014812; GO:0014902; GO:0016020; GO:0016021; GO:0019903; GO:0030534; GO:0032675; GO:0042593; GO:0045944; GO:0046777; GO:0048012; GO:0048754; GO:0050804; GO:0050918; GO:0051450; GO:0055013; GO:0060048; GO:0060079; GO:0060665; GO:0071526; GO:0071635; GO:0072593; GO:0098794; GO:1900407; GO:1900745; GO:1901299; GO:2001028	0	0	0	PF07714;PF01437;PF01403;PF01833;	4533	m.26892	59396	278817.25	441964.5	100422.4	75555	87041.5	1927668	49157	98312.25	69018.25	2.333509368
CHOYP_MRP1.10.10	Q8CG09	m.64931	sp	MRP1_RAT	46.497	1570	782	19	4	1554	2	1532	0	1395	MRP1_RAT	reviewed	Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter)	x	Abcc1 Mrp1	Rattus norvegicus (Rat)	1532	cell chemotaxis [GO:0060326]; daunorubicin transport [GO:0043215]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908]	GO:0005324; GO:0005524; GO:0005737; GO:0005886; GO:0005887; GO:0006855; GO:0006979; GO:0008559; GO:0015238; GO:0015431; GO:0015562; GO:0015911; GO:0016020; GO:0016323; GO:0016491; GO:0030335; GO:0033700; GO:0034040; GO:0034634; GO:0034775; GO:0042493; GO:0042908; GO:0043215; GO:0046618; GO:0046624; GO:0055085; GO:0060326; GO:1901215	0	0	0	PF00664;PF00005;	4871	m.64931	70780.33333	34651.66667	293493.5	50868.66667	44886.33333	142494	333917.6667	33090	172906.5	57362.4	1.495451239
CHOYP_RNP1B.1.1	P04792	m.59889	sp	HSPB1_HUMAN	36.145	83	52	1	46	127	89	171	9.52E-09	54.7	HSPB1_HUMAN	reviewed	Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27)	x	HSPB1 HSP27 HSP28	Homo sapiens (Human)	205	cellular response to vascular endothelial growth factor stimulus [GO:0035924]; intracellular signal transduction [GO:0035556]; movement of cell or subcellular component [GO:0006928]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; regulation of autophagy [GO:0010506]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mRNA stability [GO:0043488]; regulation of translational initiation [GO:0006446]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; retina homeostasis [GO:0001895]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]	GO:0000502; GO:0001895; GO:0005080; GO:0005615; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0006446; GO:0006469; GO:0006928; GO:0006986; GO:0008426; GO:0009615; GO:0010506; GO:0019901; GO:0030018; GO:0031012; GO:0032731; GO:0035556; GO:0035924; GO:0038033; GO:0042535; GO:0042802; GO:0043066; GO:0043122; GO:0043130; GO:0043488; GO:0043536; GO:0044822; GO:0045766; GO:0048010; GO:0070062; GO:0070527; GO:1902176; GO:2001028	0	0	0	PF00011;	5723	m.59889	1996542	25739	171339.5	665833.5	17751	388418.5	80537.5	6428505	591267.3333	768276.25	2.869800582
CHOYP_SC31A.1.2	O57521	m.8241	sp	HS90B_DANRE	76.718	262	56	2	1	258	465	725	7.55E-140	412	HS90B_DANRE	reviewed	Heat shock protein HSP 90-beta	x	hsp90ab1 hsp90b	Danio rerio (Zebrafish) (Brachydanio rerio)	725	blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; protein folding [GO:0006457]; response to estrogen [GO:0043627]; response to stress [GO:0006950]	GO:0001568; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006950; GO:0007517; GO:0043627; GO:0050900	0	0	0	PF02518;PF00183;	5990	m.8240	9164404.2	1361520.667	116619.3333	185248.3333	1829547	9327987.6	1016510.25	4068249	527168.6667	15804239.17	2.428958677
CHOYP_SMP_049250.1.1	P42930	m.1835	sp	HSPB1_RAT	32.71	107	70	2	15	119	67	173	5.31E-08	55.1	HSPB1_RAT	reviewed	Heat shock protein beta-1 (HspB1) (Heat shock 27 kDa protein) (HSP 27)	x	Hspb1 Hsp27	Rattus norvegicus (Rat)	206	aging [GO:0007568]; cellular response to butyrate [GO:1903545]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to interleukin-11 [GO:0071348]; female pregnancy [GO:0007565]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced cell death [GO:1903202]; positive regulation of neuron projection development [GO:0010976]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to muscle stretch [GO:0035994]	GO:0000502; GO:0002931; GO:0005634; GO:0005737; GO:0005819; GO:0005886; GO:0007565; GO:0007568; GO:0010976; GO:0030424; GO:0030425; GO:0031430; GO:0031674; GO:0035994; GO:0043066; GO:0043130; GO:0043204; GO:0045202; GO:0070301; GO:0071348; GO:0097512; GO:0098839; GO:1903202; GO:1903545; GO:1990776	0	0	0	PF00011;	6101	m.1835	150372	1061472	56760	1460974	15160	131588.5	1822599	21110	39365	431946	0.891381436
CHOYP_SODM.1.2	P04179	m.45531	sp	SODM_HUMAN	63.182	220	79	2	6	224	2	220	3.23E-102	298	SODM_HUMAN	reviewed	Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)	x	SOD2	Homo sapiens (Human)	222	age-dependent response to reactive oxygen species [GO:0001315]; negative regulation of cell proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; oxygen homeostasis [GO:0032364]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of transcription from RNA polymerase II promoter [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; superoxide metabolic process [GO:0006801]; vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure [GO:0003069]	GO:0000302; GO:0000303; GO:0001315; GO:0001836; GO:0003069; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006801; GO:0008217; GO:0008285; GO:0019430; GO:0030145; GO:0032364; GO:0042802; GO:0043524; GO:0051289; GO:0070062; GO:1902176	0	0	0	PF02777;PF00081;	6155	m.45530	78490.66667	205071	1617600.75	761757.5	19247.5	55224.5	179952	489340.6667	436601.75	183744	0.501409013
CHOYP_STIP1.2.2	P31948	m.54723	sp	STIP1_HUMAN	52.065	557	243	5	24	576	7	543	0	551	STIP1_HUMAN	reviewed	Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521)	x	STIP1	Homo sapiens (Human)	543	response to stress [GO:0006950]	GO:0005634; GO:0005794; GO:0006950; GO:0043209; GO:0043234; GO:0044822	0	0	0	PF13414;PF07719;PF13181;	6204	m.54723	277224.5	239394.2857	564827.6	542207.6923	112510.4	1514133	336436.5833	1347760.615	276059.2143	9033543.176	7.204347714
CHOYP_TRAP1.1.1	Q5XHZ0	m.60651	sp	TRAP1_RAT	60.777	566	216	4	13	574	143	706	0	720	TRAP1_RAT	reviewed	Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)	x	Trap1 Hsp75	Rattus norvegicus (Rat)	706	negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; response to stress [GO:0006950]; translational attenuation [GO:0009386]	GO:0005524; GO:0005654; GO:0005743; GO:0005758; GO:0005759; GO:0005811; GO:0006457; GO:0006950; GO:0009386; GO:0019901; GO:0044822; GO:0070062; GO:1901856; GO:1903751	0	0	0	PF00183;	6426	m.60651	580726.1818	659955.9333	270457.4545	147976.0667	1759394.467	2201730.882	3965564.308	237882.6429	877740.7222	1262641.474	2.499790778
CHOYP_contig_012079	P74897	m.13840	sp	YQA3_THEAQ	30.612	147	88	4	4	150	3	135	9.77E-11	59.3	YQA3_THEAQ	reviewed	Universal stress protein in QAH/OAS sulfhydrylase 3'region (USP)	x	0	Thermus aquaticus	137	response to stress [GO:0006950]	GO:0006950	0	0	0	PF00582;	1377	m.13839	NA	58863	32283	35933	28376	706159.6667	27690	30125	493471.25	54103	6.749471766
CHOYP_contig_050645	Q08420	m.60289	sp	SODE_RAT	26.667	150	103	6	31	179	48	191	1.87E-09	58.9	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	x	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303; GO:0001666; GO:0004784; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0005802; GO:0006979; GO:0008270; GO:0031012; GO:0046688; GO:0070062	0	0	cd00305;	PF00080;	1664	m.60289	149280	145904.5	715463.6	294631.5	178660.6667	579099.6667	494118	846515.83	402935	452613.6	1.870211463